Exenatidedosage
60 ACTUAT exenatide 0.01 MG/ACTUAT Pen Injector
Dosage and administration
Inject subcutaneously within 60 minutes prior to morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart).
Initiate at 5 mcg per dose twice daily; increase to 10 mcg twice daily after 1 month based on clinical response.
2.1 Recommended
Dosing
Initiate BYETTA at 5 mcg administered subcutaneously twice daily at any time within the 60-minute period before the morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart). Do not administer after a meal.
Based on clinical response, the dose of BYETTA can be increased to 10 mcg twice daily which is recommended after 1 month of therapy, in order to reduce the risk of gastrointestinal adverse reactions.
Administer as a subcutaneous injection in the thigh, abdomen, or upper arm.
Rotate injections sites with each dose. Do not use the same site for each injection.
Inspect visually for particulate matter and discoloration. Only use BYETTA if the solution appears clear, colorless, and contains no particles.
When using BYETTA with insulin, administer as separate injections and never mix. It is acceptable to inject BYETTA and insulin in the same body region, but the injections should not be adjacent to each other.
If a dose is missed, resume the treatment regimen as prescribed with the next scheduled dose.
2.1 Recommended
Dosing
Initiate BYETTA at 5 mcg administered subcutaneously twice daily at any time within the 60-minute period before the morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart). Do not administer after a meal.
Based on clinical response, the dose of BYETTA can be increased to 10 mcg twice daily which is recommended after 1 month of therapy, in order to reduce the risk of gastrointestinal adverse reactions.
Administer as a subcutaneous injection in the thigh, abdomen, or upper arm.
Rotate injections sites with each dose. Do not use the same site for each injection.
Inspect visually for particulate matter and discoloration. Only use BYETTA if the solution appears clear, colorless, and contains no particles.
When using BYETTA with insulin, administer as separate injections and never mix. It is acceptable to inject BYETTA and insulin in the same body region, but the injections should not be adjacent to each other.
If a dose is missed, resume the treatment regimen as prescribed with the next scheduled dose.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective September 2, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance